Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Director's Dealing 2021

Dec 12, 2021

3535_dirs_2021-12-12_5bcec6fc-ae76-4e85-813f-ecada4c28260.html

Director's Dealing

Open in viewer

Opens in your device viewer

AQUA BIO TECHNOLOGY ASA - PRIMARY INSIDER NOTIFICATIONS

AQUA BIO TECHNOLOGY ASA - PRIMARY INSIDER NOTIFICATIONS

13.12.2021 00:40:04 CET | Aqua Bio Technology ASA | Mandatory notification of

trade primary insiders

Aqua Bio Technology ASA - Primary insider Notifications

Reference is made to the stock exchange notice from Aqua Bio Technology ASA (the

"Company") regarding the completion of a private placement to raise NOK 12.89

million.

In the private placement Håvard Lindstrøm, CEO and primary insider the Company,

has been allocated 71 429 shares at a price of NOK 14 per share, through his

wholly owned company Ice Capital AS. Following such allocation, Håvard Lindstrøm

and related parties will, upon issuance of shares in the private placement, hold

416 348 shares in the Company, corresponding to an ownership stake of 2.0% of

the total outstanding shares in the Company.

Roger Hofseth, board member and primary insider of ABT, has been allocated 178

571 shares today at a price of NOK 14 per share, through his wholly owned

company RH Industri AS. Following such allocation, Roger Hofseth and related

parties will, upon issuance of shares in the private placement, hold 4 693 475

shares in the Company, corresponding to an ownership stake of 22.76% of the

total outstanding shares in the Company.

Jan Petterson, board member and primary insider of ABT, has been allocated 107

143 shares today at a price of NOK 14 per share. Following such allocation, Jan

Petterson and related parties will, upon issuance of shares in the private

placement, hold 4 543 028 shares in the Company, corresponding to an ownership

stake of 22.03% of the total outstanding shares in the Company.

Espen Halvard Dahl, a close associate of Board member Kristin Aase who is a

primary insider in the Company, has been allocated 71 429 shares at a price of

NOK 14. Following such allocation, Espen Halvard Dahl, Kjeveortoped Espen Dahl

AS and close associates (including Board member Kristin Aase) will, upon

issuance of shares in the private placement, hold 1 477 707 shares in the

company, corresponding to an ownership stake of 7.17% of the total outstanding

shares in the Company.

Further information is available in the attached forms.

****

For further information, please contact Håvard Lindstrøm, CEO, telephone +47 941

32 288.

This information is subject to the disclosure requirements in Regulation EU

596/2014 article 19 number 3 and the Norwegian Securities Trading Act § 5-12.

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

effective and they provide the cosmetics industry with natural alternatives to

traditional ingredients. ABT is also marketing and distributing natural skin

care products developed by partners towards consumers and professional users.

ABT's focus on commercialization and development of natural ingredients and

natural skin care products has been, and will continue to be, an important part

of the company's strategy going forward. Aqua Bio Technology is listed on

Euronext Expand.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, [email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/1060/1427/Download%20announcement

%20as%20PDF.pdf

Ice Capital AS.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/1060/1424/Ice%20Capital%20AS.pdf

RH Industri AS.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/1060/1425/RH%20Industri%20AS.pdf

EH Dahl Jan Petterson.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/1060/1426/EH%20Dahl%20%20Jan%20Pe

tterson.pdf